BardelliLab's profile picture. Clonal evolution and drug resistance: from cancer avatars to liquid biopsies.

Bardelli Lab

@BardelliLab

Clonal evolution and drug resistance: from cancer avatars to liquid biopsies.

Bardelli Lab reposted

Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer dlvr.it/TM0DWX

Cancer_Cell's tweet image. Induction of a mismatch repair deficient genotype by tailored chemical mutagenesis in experimental models of cancer dlvr.it/TM0DWX

Bardelli Lab reposted

Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models dlvr.it/TM0Npb

Cancer_Cell's tweet image. Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models dlvr.it/TM0Npb

Bardelli Lab reposted

ecDNA fuels cancer progression: large, mobile circles of DNA in tumors drive high oncogene copies & rapid genetic changes. Their random spread during cell division increases treatment resistance & tumor evolution. Determining therapeutic vulnerabilities & identifying target

jsoriamd's tweet image. ecDNA fuels cancer progression: large, mobile circles of DNA in tumors drive high oncogene copies & rapid genetic changes. Their random spread during cell division increases treatment resistance & tumor evolution. Determining therapeutic vulnerabilities & identifying target

Bardelli Lab reposted

A great overview/update of this burgeoning field! Still a lot of unanswered questions, but exciting time ahead! Happy we could contribute to this field and comprehensive overview. Thanks to @BardelliLab for taking the lead.

Hot off the press! We are proud to share our Roadmap on Cancer Persister Cells just published on @NatureRevCancer, a joint effort with outstanding scientists in the field to outline challenges and (exciting) future perspectives Persisters: rdcu.be/dSJp4



Bardelli Lab reposted

📢This week in @NatureRevCancer, a joint effort by many groups led by the @BardelliLab on #Cancer Persister cells. 🙌🏻It’s been a pleasure to contribute to this roadmap. ➡️rdcu.be/dSJp4

BatlleLab's tweet image. 📢This week in  @NatureRevCancer, a joint effort by many groups led by the @BardelliLab on #Cancer Persister cells.

🙌🏻It’s been a pleasure to contribute to this roadmap.

➡️rdcu.be/dSJp4

Hot off the press! We are proud to share our Roadmap on Cancer Persister Cells just published on @NatureRevCancer, a joint effort with outstanding scientists in the field to outline challenges and (exciting) future perspectives Persisters: rdcu.be/dSJp4


Bardelli Lab reposted

Excited to share the #Pezcoller23 Symposium final program, with a tremendous lineup of speakers! 💡 NEW TECHNOLOGIES FOR STUDYING AND TREATING CANCER 🗓️19-20 June 🇮🇹 Trento ⏳ Still few days to register, deadline: 31/05👉 lnkd.in/etYSdNMX @ESOncology recommended event

pezcoller's tweet image. Excited to share the #Pezcoller23 Symposium final program, with a tremendous lineup of speakers!

💡 NEW TECHNOLOGIES FOR STUDYING AND TREATING CANCER
🗓️19-20 June 🇮🇹 Trento

⏳ Still few days to register, deadline: 31/05👉 lnkd.in/etYSdNMX

@ESOncology recommended event
pezcoller's tweet image. Excited to share the #Pezcoller23 Symposium final program, with a tremendous lineup of speakers!

💡 NEW TECHNOLOGIES FOR STUDYING AND TREATING CANCER
🗓️19-20 June 🇮🇹 Trento

⏳ Still few days to register, deadline: 31/05👉 lnkd.in/etYSdNMX

@ESOncology recommended event

Bardelli Lab reposted

⁦⁩ 💞specifically for ⁦@KRASKickers energy & motivation ⁩ during #EACR2023@AmbrogioLab

TerriConneran's tweet image. ⁦⁩ 💞specifically for ⁦@KRASKickers energy & motivation ⁩ during #EACR2023  ⁦@AmbrogioLab⁩

Bardelli Lab reposted

Today at the #EACRCongress in Torino inspiring talk on liquid biopsy and its clinical application by dr. Marsoni. Do not miss upcoming news in the next months! @EACRnews @eacr2023

IFOMresearch's tweet image. Today at the #EACRCongress in Torino inspiring talk on liquid biopsy and its clinical application by dr. Marsoni. Do not miss upcoming news in the next months!
@EACRnews  @eacr2023
IFOMresearch's tweet image. Today at the #EACRCongress in Torino inspiring talk on liquid biopsy and its clinical application by dr. Marsoni. Do not miss upcoming news in the next months!
@EACRnews  @eacr2023
IFOMresearch's tweet image. Today at the #EACRCongress in Torino inspiring talk on liquid biopsy and its clinical application by dr. Marsoni. Do not miss upcoming news in the next months!
@EACRnews  @eacr2023

Bardelli Lab reposted

Wonderful talk by Yaara Oren kicking off the session on cancer persisters at #EACR2023. Did you know she trained as microbiologist? Thinking outside the box! @EACRnews @BardelliLab

AlbertoSogari's tweet image. Wonderful talk by Yaara Oren kicking off the session on cancer persisters at #EACR2023. Did you know she trained as microbiologist? Thinking outside the box! @EACRnews @BardelliLab

Bardelli Lab reposted

Amazing overview of the last ten years of research in colorectal cancer pointing towards new exciting ones by Prof. Bardelli at #EACR2023. @BardelliLab @EACRnews

IFOMresearch's tweet image. Amazing overview of the last ten years of research in colorectal cancer pointing towards new exciting ones by Prof. Bardelli at #EACR2023.
@BardelliLab  @EACRnews
IFOMresearch's tweet image. Amazing overview of the last ten years of research in colorectal cancer pointing towards new exciting ones by Prof. Bardelli at #EACR2023.
@BardelliLab  @EACRnews
IFOMresearch's tweet image. Amazing overview of the last ten years of research in colorectal cancer pointing towards new exciting ones by Prof. Bardelli at #EACR2023.
@BardelliLab  @EACRnews
IFOMresearch's tweet image. Amazing overview of the last ten years of research in colorectal cancer pointing towards new exciting ones by Prof. Bardelli at #EACR2023.
@BardelliLab  @EACRnews

Bardelli Lab reposted

Great lecture of @Albert0Bardelli @BardelliLab yesterday at @EACRnews meeting explaining how targeting of MLH1 and temozolamide treatment can engage #immunotherapy response in #coloncancer

ManelEsteller's tweet image. Great lecture of @Albert0Bardelli @BardelliLab yesterday at @EACRnews  meeting explaining how targeting of MLH1 and temozolamide treatment can  engage #immunotherapy response in #coloncancer

Bardelli Lab reposted

@AmbrogioLab rocking at Ras symposium today #EACR2023

Sandra_Misale's tweet image. @AmbrogioLab rocking at Ras symposium today #EACR2023

Bardelli Lab reposted

Huge congratulations to EACR Board member Carlos Caldas on this award! @CaldasLab 🥳

Carlos was awarded the @FondationARC Léopold Griffuel Award at the European Parliament in Strasbourg today: "I stand on the shoulders of my amazing laboratory group. I share this enormous honour with all of them!" Look forward to his talk at #EACR2023 on 13/6 at 4.30 pm! #bcsm

CaldasLab's tweet image. Carlos was awarded the @FondationARC Léopold Griffuel Award at the European Parliament in Strasbourg today: "I stand on the shoulders of my amazing laboratory group. I share this enormous honour with all of them!"

Look forward to his talk at #EACR2023 on 13/6 at 4.30 pm!
#bcsm


Day 3 begins with a great talk by #ChiaraCattaneo on "Dissecting Tumor-immune Cells Interactions: Functional Models for Individual Patients". @EACRnews @IFOMresearch #EACR2023

BardelliLab's tweet image. Day 3 begins with a great talk by #ChiaraCattaneo on "Dissecting Tumor-immune Cells Interactions: Functional Models for Individual Patients".
@EACRnews @IFOMresearch #EACR2023

Bardelli Lab reposted

Today at #EACR2023 Giovanni Crisafulli just presented new super interesting data on T-cell repertoire after temozolomide treatment from the #Arethusatrial patients. What’s next from this proof-of-concept trial? Stay tuned! @BardelliLab @EACRnews @eacr2023

IFOMresearch's tweet image. Today at #EACR2023 Giovanni Crisafulli just presented new super interesting data on T-cell repertoire after temozolomide treatment from the #Arethusatrial patients. What’s next from this proof-of-concept trial? Stay tuned! 
@BardelliLab  @EACRnews  @eacr2023
IFOMresearch's tweet image. Today at #EACR2023 Giovanni Crisafulli just presented new super interesting data on T-cell repertoire after temozolomide treatment from the #Arethusatrial patients. What’s next from this proof-of-concept trial? Stay tuned! 
@BardelliLab  @EACRnews  @eacr2023
IFOMresearch's tweet image. Today at #EACR2023 Giovanni Crisafulli just presented new super interesting data on T-cell repertoire after temozolomide treatment from the #Arethusatrial patients. What’s next from this proof-of-concept trial? Stay tuned! 
@BardelliLab  @EACRnews  @eacr2023

Great talk by @fcicca Cancer-immune coevolution. Players and mechanisms of response of CRC to immunotherapy! @EACRnews #EACR2023

BardelliLab's tweet image. Great talk by @fcicca Cancer-immune coevolution. Players and mechanisms of response of CRC to immunotherapy!
@EACRnews  #EACR2023

It is always a pleasure to watch past students of our lab to fligh high as scientists! Great #GiuliaLerda! Great talk! @EACRnews

BardelliLab's tweet image. It is always a pleasure to watch past students of our lab to fligh high as scientists!
Great #GiuliaLerda! Great talk!
@EACRnews

If you are interested in our work..join our group!!! We have open positions!!!#hiring #HIRINGNOW

Great start of day 2 at #EACR2023 with drug resistance session, wonderful talk by @mariangelaruss2 from @BardelliLab on innovative concepts in cancer persisters evolution and new approaches to eradicate them exploiting DNA damage and DDR inhibitors! Exciting science @EACRnews

AlbertoSogari's tweet image. Great start of day 2 at #EACR2023 with drug resistance session, wonderful talk by @mariangelaruss2 from @BardelliLab on innovative concepts in cancer persisters evolution and new approaches to eradicate them exploiting DNA damage and DDR inhibitors! Exciting science @EACRnews


Loading...

Something went wrong.


Something went wrong.